Persistent URL of this record https://hdl.handle.net/1887/3567007
Documents
-
- Download
- Full text
- Publisher's Version
- open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer
- All authors
- Hoorn, S. ten; Waasdorp, C.; Oijen, M.G.H. van; Damhofer, H.; Trinh, A.; Zhao, L.; Smits, L.J.H.; Bootsma, S.; Pelt, G.W. van; Mesker, W.E.; Mol, L.; Goey, K.K.H.; Koopman, M.; Medema, J.P.; Tuynman, J.B.; Zlobec, I.; Punt, C.J.A.; Vermeulen, L.; Bijlsma, M.F.
- Date
- 2022-04-12
- Journal
- BMC Cancer
- Volume
- 22
- Issue
- 1